These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22932454)

  • 41. [Pulmonary neuroendocrine cell hyperplasia and tumorlets in bronchiectasis: a clinicopathologic study of 22 cases with review of literature].
    Huo Z; Shi XH; Cui QC; Luo YF; Cao JL; Liu HR
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):525-9. PubMed ID: 23157743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
    Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Association of neuroendocrine differentiation with progression and prognosis of gastric adenocarcinoma].
    Xu F; Liu Q; Han F; Xu E; Lai M; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):24-30. PubMed ID: 27045237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.
    Dhall D; Mertens R; Bresee C; Parakh R; Wang HL; Li M; Dhall G; Colquhoun SD; Ines D; Chung F; Yu R; Nissen NN; Wolin E
    Hum Pathol; 2012 Apr; 43(4):489-95. PubMed ID: 21937080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
    Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
    Farrell JM; Pang JC; Kim GE; Tabatabai ZL
    Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
    Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
    Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiogenesis and vascular maturation in neuroendocrine tumors.
    Yazdani S; Kasajima A; Tamaki K; Nakamura Y; Fujishima F; Ohtsuka H; Motoi F; Unno M; Watanabe M; Sato Y; Sasano H
    Hum Pathol; 2014 Apr; 45(4):866-74. PubMed ID: 24656098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can the Ki-67 Labeling Index in Biopsy Specimens Predict the World Health Organization Grade of Rectal Neuroendocrine Tumors?
    Sugimoto S; Hotta K; Shimoda T; Imai K; Ito S; Yamaguchi Y; Takizawa K; Kakushima N; Tanaka M; Kawata N; Yoshida M; Ishiwatari H; Matsubayashi H; Ono H
    Dig Dis; 2018; 36(2):118-122. PubMed ID: 29130971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.
    Ćwikła JB; Bodei L; Kolasinska-Ćwikła A; Sankowski A; Modlin IM; Kidd M
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1437-45. PubMed ID: 26348352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroendocrine Differentiation in Thymic Carcinomas: A Diagnostic Pitfall: An Immunohistochemical Analysis of 27 Cases.
    Weissferdt A; Moran CA
    Am J Clin Pathol; 2016 Mar; 145(3):393-400. PubMed ID: 27124922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z; Tang LH; Klimstra DS
    Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
    Ding HY; Gao LX
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
    Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
    Boyar Cetinkaya R; Vatn M; Aabakken L; Bergestuen DS; Thiis-Evensen E
    Scand J Gastroenterol; 2014 Jun; 49(6):734-41. PubMed ID: 24679166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating tumor cells as prognostic markers in neuroendocrine tumors.
    Khan MS; Kirkwood A; Tsigani T; Garcia-Hernandez J; Hartley JA; Caplin ME; Meyer T
    J Clin Oncol; 2013 Jan; 31(3):365-72. PubMed ID: 23248251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current status of the histopathological assessment, diagnosis, and reporting of colorectal neuroendocrine tumors: A Web survey from the Japanese Society for Cancer of Colon and Rectum.
    Ikeda K; Kojima M; Saito N; Sakuyama N; Koushi K; Watanabe T; Sugihara K; Akimoto T; Ito M; Ochiai A
    Pathol Int; 2016 Feb; 66(2):94-101. PubMed ID: 26814047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
    La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
    Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols.
    Eren OC; Bagci P; Balci S; Ohike N; Saka B; Sokmensuer C; Leblebici CB; Xue Y; Reid MD; Krasinskas AM; Kooby D; Maithel SK; Sarmiento J; Cheng JD; Taskin OC; Kapran Y; Tarcan ZC; Luchini C; Scarpa A; Basturk O; Adsay NV
    Ann Surg Oncol; 2024 Oct; 31(10):7001-7011. PubMed ID: 38955993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.